Class II
Ongoing
Abirtega (abiraterone acetate) USP, 250 mg, 120-count bottles, Rx only, Rx only, Mfd for: Hikma Pharmaceuticals USA Inc., Berkley Heights, NJ 07922 USA by: Arab Pharmaceuticals Manufacturing PSC PO Bo…
Why: Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.
- Company
- Hikma Pharmaceuticals USA INC.
Columbus, OH, United States - Reported
- Oct 28, 2026
- Recall started
- Oct 6, 2026
- Where sold
- Nationwide within the United States
- Amount
- 2136 bottles
- Full product description
- Abirtega (abiraterone acetate) USP, 250 mg, 120-count bottles, Rx only, Rx only, Mfd for: Hikma Pharmaceuticals USA Inc., Berkley Heights, NJ 07922 USA by: Arab Pharmaceuticals Manufacturing PSC PO Box 41, Sahab-Jordon, NDC 82249-011-12.
- Lots / codes affected
- Lot #: 3047, Exp Date July 2027.
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.